Aminoethyl-isothiourea in gram-positive shock: An inhibitor of inducible nitric oxide synthase or a jack-of-all-trades?

Shock

Volumn 15, Issue 6, 2001, Pages 453-454

  Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOETHYL ISOTHIOUREA; AMINOETHYL-ISOTHIOUREA; DRUG DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; THIOUREA;

ANIMAL; BACTERIAL INFECTION; DRUG ANTAGONISM; HUMAN; NOTE; SEPTIC SHOCK;

ANIMALS; ENZYME INHIBITORS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SHOCK, SEPTIC; THIOUREA;

EID: 0035375298     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-200115060-00007     Document Type: Editorial

References (23)

1. Thiemermann C: Nitric oxide and septic shock. Get: Pharmacol 29:159-166, 1997 (Pubitemid 27312364)
2. Bone RC: Gram-positive organisms and sepsis, Arch Intern Med 154:26 34, 1994. (Pubitemid 24018098)
3. Pittel D, Wenzel RP: Nosocomial blood stream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155:1177-1184, 1995.
4. Danner RL, Elin RJ, Hosseini JM: Endotoxemia in human septic shock. Chest 99:169 175, 1991.
5. Natanson C, Danner RL, Elin RJ: Role of endotoxemia in cardiovascular dysfunction and mortality-E. colt and S. aureus challenges in a canine model of human septic shock. J Clin Invest 83:243-251. 1989.
6. Wakubaytishi G, Geland JA. Jung WK: S, epidermidis induces complement activation, tumor necrosis factor and interleukin-1. a shock like state and lissuc injury in rabbits without endotoxemia-comparison to E. coll. J Clin Invest 87:1925-1935, 1991.
7. De Kimpe SJ. Kengatharan M. Thiemermann C, Vane JR: The cell wall components peptidoglycan and lipoteichoic acid from streptococcus aureus synergize to cause shock and multiple organ failure. Proc Nail Acad Sci USA 92:10359-10363, 1995.
8. Kengatharan KM. DelKimpe S, Robson C. Foster SJ, Thiemermann C: Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential for the induction of nitric oxide synthase, shock and multiple organ failure. J Exp Med 188:305-315, 1998. (Pubitemid 28357759)
9. Soulhan G. Szabo C, Thiemermann C: Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J. Pharmacol 114:510-516, 1995.
10. Garvey PE, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M. Marshall S. Marnion MF, Paith JE, Furfine ES: Potent and selective inhibition of human nitric oxide synthases: inhibition by non-ammo acid isothioureas. J Biol Chem 269:26669-26676, 1994.
11. Szabo C. Soulhan G. Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isolhioiuca sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
12. Thiemermann C. Ruetten H. Wu CC. Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851. 1995.
13. Saetre T, Gundersen Y. Thiemermann C, Lilleaasen P, Aasen A: Amino-ethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation ami oxygen metabolism in a porcine model of endotoxaemia. Slunk 9:109-115. 1997.
14. Arieni M. Pospisil J. Dienstbier Z, Vetrovcova E: Effect of prophylactic administration of AET (amino-ethyl-isoihiouronium-bromide-hydrobromide) on liematological changes in irradiated rats. Strahlentherapie 139:619-625. 1970.
15. Valles EG, de Castro CR, Castro JA: Late protective effects against CC14-induced liver necrosis by the radioprotective agent 2-aniinoethyl- isothiouronium bromide hydrobromide (AET). Toxicology 90:71-80, 1994. (Pubitemid 24193491)
16. Ruetten H, Thiemermann C: Prevention ol the expression of inducible nitric oxide synthase by aminoguanidine or aininoelhyl-isolhioiirea in macrophages anil in the rat. Biochem Biophys Res Commun 225:525-530, 1992. (Pubitemid 26355634)
17. Soulhan GJ, Zingarelli B. O'Conner M. Salzman AL, Szabo C: Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkyl-guanidines. a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117:619 632, 1996. (Pubitemid 26070239)
18. Zingarelli B, Soulhan GJ, Gilad E, O'Connor M. Salzman AL, Szabo C: The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Br J Pharmacol 120:357-366, 1997. (Pubitemid 27053977)
19. Szabo C. Ferrer-Sueta G. Zingarelli B. Southun GJ. Salzman AL. Kadi K: Mercaploclhylguauidiue and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol. Chem 272:9030-9036, 1997. (Pubitemid 27154903)
20. Wihnoll RW. Kitzmiller JA. Szabo C. Soulhan GJ. Salzman AL: Mercap-toethylguunidine inhibits the inflammatory response in a muriue model of chronic infection with Pseudomonas aeruginosa. J Pharmacol Exp Ther 292:88-95, 2011.
21. Garvey EP, Oplinger JA. Furfine ES, Kill RJ. Laszlo F, Whittle BJR, Knowles RG: 1400W is a slow, light binding, anil highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963, 1997. (Pubitemid 27090046)
22. Moore WM. Webber RK, Jerome GM, Tjoeng IS. Misko TP, Currie MG: l.-N6-(1-iininoelhyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37:3886-3888. 1994.
23. Wray GM. Miller CG, Hinds CJ, Thiemermann C: Selective inhibition of inducible nitric oxide synthase prevents the circulatory failure, bill noi the organ injury/dysfunction caused by endotoxin. Shock 9:329-335, 1998. (Pubitemid 128463880)